The cofounders of AZmed are nominated as Forbes 30 Under 30

During routine processing, AZtrauma analyses each fracture’s edge sharpness, callus density, and cortical continuity, the same cues radiologists use, then assigns a probability score. When the algorithm crosses the “old-fracture” threshold, it writes FRAC. (old) in black text inside the standard white bounding box on the secondary capture; otherwise, the label remains FRAC. in red. The bounding box itself never changes colour, preserving visual consistency.

The EU-REST project warns that shortages lengthen cancer-staging pathways and delay emergency interventions. Understaffing raises radiation dose because over-worked teams skip protocol optimisation. Diagnostic inequity widens between metropolitan hubs and peripheral clinics. Meanwhile, AI still needs human oversight; without enough clinicians, algorithmic alerts risk being ignored. Sustainable deployment therefore demands that every recommendation of the project, and every promise of the wider AI ecosystem, converge on the same staffing blueprint.

Why FDA AI Matters to Timelines

Medicines. Under the Prescription Drug User Fee Act (PDUFA), FDA aims to act on new drug and Biologics License Applications within 6 months for priority files and 10 months for standard submissions, effectively a 6 to 10-month window.⁴

Software as a Medical Device (SaMD). For 510(k) clearances, the route AZmed’s Rayvolve® X-ray suite follows, the statutory review clock is 90 FDA days.⁵ In practice, iterative “additional-information” cycles frequently stretch total elapsed time to 180 days; if questions are not resolved within that period the file is withdrawn.

Most of that lag involves document-completeness checks, manual code-list comparisons and repetitive safety-endpoint queries, exactly the clerical busywork Elsa is designed to absorb. Internal modelling suggests that if Elsa trims even 25% of administrative “touch-time” (the gain observed in pilot testing), real-world clearance dates for imaging AI could advance by four to six weeks, with even larger effects on complex De Novo submissions.